Evidence map›Paper›PMID 40117063›Full record

ArticleCardiology and therapy2025

The Atrial FibriLlatiOn Registry (FLOW-AF): Patient Characteristics, Treatment Patterns, and Outcomes in Egypt.

Mohamed Sobhy, Magdy Abdelhamid, Adel Mohamed El Etriby, Mohamed Fathy Soliman Gamaleldin, Ahmed Mohamed Helmy Youssef, Natasha Khalife, Hany Ragy, Ashraf Reda, Maichel Sobhy, Mostafa Nawar

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cardiology and therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Mohamed SobhyInternational Cardiac Center Hospital, 24 Bahaa Eldin Elghatwary St. Semouha, Alexandria, Egypt. sobhy53@yahoo.com.
Magdy AbdelhamidPrivate Clinic, 09 El Saha St., Bab El Louk, Cairo, 19014, Egypt.
Adel Mohamed El EtribyPrivate Clinic, 23 El Emam Aly St., Ismaileya Square, Heliopolis, Cairo, Egypt.
Mohamed Fathy Soliman GamaleldinPfizer Gulf, Sheikh Zayed Road, Al Moosa Tower 2, PO Box 29553, Dubai, United Arab Emirates.
Ahmed Mohamed Helmy YoussefPfizer Egypt, Egypt Scientific Office, 5th Settlement, Cairo Festival City, Taha Hussein Street, Podium Building Number 4, 5th Floor, Cairo, Egypt.
Natasha KhalifeDubai World Trade Center, IQVIA, Real-World Evidence, UAE Convention Tower, 11th Floor, Dubai, United Arab Emirates.
Hany RagyCardiocath Medical Private Center, 39 El-Khalifa El-Maamoun, El-Montaza, Heliopolis, Cairo, Egypt.
Ashraf RedaPrivate Clinic, 127 Mohamed Farid St, Bab El Louk, Cairo, Egypt.
Maichel SobhyPrivate Clinic, Cairo University, 108 El Manial Street, Cairo, Egypt.
Mostafa NawarPrivate Clinic, 03 Koliat El Tab, El Ramel Station, Alexandria, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionReal-world data on atrial fibrillation (AF) in the Middle East and North Africa (MENA) region, including Egypt, are sparse. The aim of the FLOW-AF registry was to evaluate the characteristics, treatment patterns, and clinical and economic outcomes of newly diagnosed non-valvular atrial fibrillation (NVAF) patients within the MENA region, including Egypt.

methodsThis multicenter, prospective, observational registry enrolled newly diagnosed patients with NVAF from January 2020 to December 2022 at eight private-sector healthcare centers in Egypt. Data were collected at enrollment (baseline), and then at 6-month and 12-month follow-up. Baseline data included demographics, AF characteristics, medical history, and antithrombotic treatment patterns. Follow-up data included clinical events, healthcare resource utilization, and related costs.

resultsA total of 723 patients were enrolled. Overall, 51.87% were females, and the mean age was 61.9 years. All patients attended the private health sector. The mean (standard deviation) CHA

conclusionsThe FLOW-AF study showed that patients with NVAF in Egypt are younger and exhibit lower mean baseline CHA

Indexed as

Atrial fibrillationClinical outcomesEgyptHealthcare resource utilizationOral anticoagulants

Identifiers

PMID40117063
PMCPMC12084437

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.